A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
ANTINUCLEAR ANTIBODY QUANTITATIVE TITER by IFA
MessageThis test does not include a screen; ANA by IFA only
Test Code
ANAIF
Alias/See Also
ZANQT
CPT Codes
86039
Preferred Specimen
1 Gold tube (gel separator)
Minimum Volume
1 mL
Other Acceptable Specimens
None - alternate tube types are no longer acceptable.
Instructions
Centrifuge for complete separation of serum and red cells. Refrigerate until tested.
Transport Temperature
Refrigerate
Specimen Stability
- 15-30°C up to 8 hours
- 2-8°C up to 2 days; otherwise freeze
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Hemolyzed or lipemic samples
Methodology
IFA
Setup Schedule
M, W, F (day shift only)
Reference Range
<1:40
Clinical Significance
This test utilizes cytoplasmic and nuclear immunofluorescence patterns on HEp-2 cells to detect the presence of antibodies associated with systemic autoimmune diseases which may be helpful in the diagnosis of: systemic lupus erythematosus, scleroderma, mixed connective tissue disease, undifferentiated connective tissue disease, Sjogrens syndrome, dermatomyositis, polymyositis, primary biliary cirrhosis and auto immune hepatitis.
The test is intended for diagnostic use and is of limited clinical utility in monitoring disease course. Overlap may occur between patterns, antibodies and diseases. If a negative result is obtained in the presence of clinical signs and symptoms suggestive of systemic autoimmune disease, repeat testing using an alternative method is suggested (Multiplex bead testing/Bioplex). Positive IFA titers of 1:40 can be detected in up to 32% of healthy individuals, stressing the importance of clinical correlation. with patient signs and symptoms.
The test is intended for diagnostic use and is of limited clinical utility in monitoring disease course. Overlap may occur between patterns, antibodies and diseases. If a negative result is obtained in the presence of clinical signs and symptoms suggestive of systemic autoimmune disease, repeat testing using an alternative method is suggested (Multiplex bead testing/Bioplex). Positive IFA titers of 1:40 can be detected in up to 32% of healthy individuals, stressing the importance of clinical correlation. with patient signs and symptoms.
Performed By
Alverno Laboratories
Performing Laboratory
Alverno Central Lab
NIMEU (Immunology, Euroimmun)
Last Updated: April 25, 2023